MA43271A - Formulations améliorées de déférasirox et leurs procédés de fabrication - Google Patents
Formulations améliorées de déférasirox et leurs procédés de fabricationInfo
- Publication number
- MA43271A MA43271A MA043271A MA43271A MA43271A MA 43271 A MA43271 A MA 43271A MA 043271 A MA043271 A MA 043271A MA 43271 A MA43271 A MA 43271A MA 43271 A MA43271 A MA 43271A
- Authority
- MA
- Morocco
- Prior art keywords
- improved
- manufacturing processes
- deferasirox
- formulations
- deferasirox formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562180998P | 2015-06-17 | 2015-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43271A true MA43271A (fr) | 2018-09-26 |
Family
ID=57546755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043271A MA43271A (fr) | 2015-06-17 | 2016-06-17 | Formulations améliorées de déférasirox et leurs procédés de fabrication |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10265301B2 (fr) |
| EP (1) | EP3310354A4 (fr) |
| JP (1) | JP2018517734A (fr) |
| CN (1) | CN107847490A (fr) |
| AU (3) | AU2016280280B2 (fr) |
| CA (1) | CA2989145A1 (fr) |
| HK (1) | HK1254608A1 (fr) |
| IL (1) | IL256322B (fr) |
| MA (1) | MA43271A (fr) |
| WO (1) | WO2016205658A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2610351T3 (en) | 2007-12-05 | 2015-09-28 | Complete Genomics Inc | Base efficient provision of sequencing reactions |
| US10098857B2 (en) | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
| CA2765427A1 (fr) | 2009-06-15 | 2010-12-23 | Complete Genomics, Inc. | Procedes et compositions pour un sequencage a lecture de fragments longs |
| US10837879B2 (en) | 2011-11-02 | 2020-11-17 | Complete Genomics, Inc. | Treatment for stabilizing nucleic acid arrays |
| CZ2017255A3 (cs) * | 2017-05-04 | 2018-11-14 | Zentiva, K.S. | Filmem potažené tablety Deferasiroxu |
| WO2019055490A1 (fr) | 2017-09-14 | 2019-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | Conditionnement de tissu irradié pour rétention de greffe de graisse |
| JP7378393B2 (ja) * | 2017-11-10 | 2023-11-13 | オースティンピーエックス リミテッド ライアビリティ カンパニー | 改善された薬物製剤 |
| WO2020061474A1 (fr) * | 2018-09-20 | 2020-03-26 | Tautona Group Ip Holding Company, L.L.C. | Composés de chélation du fer pour traiter des affections cutanées esthétiques |
| EP4142699A1 (fr) | 2020-04-30 | 2023-03-08 | Nanocopoeia LLC | Comprimé à désintégration orale comprenant une dispersion solide amorphe de nilotinib |
| CN112870361A (zh) * | 2021-01-28 | 2021-06-01 | 重庆医科大学 | 铁死亡抑制剂在制备预防或治疗铁过载导致的骨质疏松或骨丢失的药物中的应用 |
| CN114994205B (zh) * | 2022-05-30 | 2023-03-28 | 上海奥科达医药科技股份有限公司 | 地拉罗司颗粒剂中相关杂质的检测方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009056D0 (en) * | 2000-04-12 | 2000-05-31 | Nestle Sa | Composition comprising free amino acids |
| AU2006303514B2 (en) * | 2005-10-19 | 2010-06-24 | Novartis Ag | Dispersible tablets comprising deferasirox |
| EP2187968A4 (fr) | 2007-08-21 | 2013-02-20 | Univ Texas | Mélange thermocinétique pour des applications pharmaceutiques |
| US20090142395A1 (en) * | 2007-11-19 | 2009-06-04 | Uri Zadok | Deferasirox pharmaceutical compositions |
| WO2009130604A2 (fr) * | 2008-04-21 | 2009-10-29 | Actavis Group Ptc Ehf | Formes à l'état solide de sels de déférasirox et leurs procédés de fabrication |
| US8772503B2 (en) * | 2009-12-07 | 2014-07-08 | Mapi Pharma Ltd. | Processes for the preparation of deferasirox, and deferasirox polymorphs |
| EP2929877A1 (fr) * | 2010-07-08 | 2015-10-14 | ratiopharm GmbH | Forme posologique orale de déférasirox |
| EP2632907B1 (fr) * | 2010-08-25 | 2015-10-14 | Davuluri, Ramamohan Rao | Procédé de préparation de 2-(2-hydroxyphényl)-benz[1,3]oxazin-4-one et son utilisation pour la préparation de deferasirox |
| PE20170468A1 (es) * | 2010-10-01 | 2017-04-26 | Cipla Ltd | Composicion farmaceutica que comprende deferasirox |
| WO2012116238A1 (fr) * | 2011-02-23 | 2012-08-30 | Dispersol Technologies, Llc | Formulations pharmaceutiques d'acide acétyl-11-céto-β-boswellique, de diindolylméthane et de curcumine pour applications pharmaceutiques |
| SI2964202T1 (sl) * | 2013-03-08 | 2019-02-28 | Novartis Ag | Peroralne formulacije deferasiroksa |
| ZA201403276B (en) * | 2013-05-10 | 2015-07-29 | Cipla Ltd | Low dose pharmaceutical composition |
-
2016
- 2016-06-17 CA CA2989145A patent/CA2989145A1/fr active Pending
- 2016-06-17 US US15/185,888 patent/US10265301B2/en active Active
- 2016-06-17 JP JP2017565048A patent/JP2018517734A/ja active Pending
- 2016-06-17 MA MA043271A patent/MA43271A/fr unknown
- 2016-06-17 WO PCT/US2016/038089 patent/WO2016205658A1/fr active Application Filing
- 2016-06-17 AU AU2016280280A patent/AU2016280280B2/en active Active
- 2016-06-17 EP EP16812529.2A patent/EP3310354A4/fr active Pending
- 2016-06-17 CN CN201680042313.0A patent/CN107847490A/zh active Pending
-
2017
- 2017-06-28 US US15/636,174 patent/US10258608B2/en active Active
- 2017-12-14 IL IL256322A patent/IL256322B/en unknown
-
2018
- 2018-10-23 HK HK18113574.7A patent/HK1254608A1/zh unknown
-
2019
- 2019-02-06 US US16/268,785 patent/US11878005B2/en active Active
-
2021
- 2021-12-02 AU AU2021277731A patent/AU2021277731B2/en active Active
-
2023
- 2023-11-24 US US18/518,819 patent/US20240091201A1/en active Pending
-
2024
- 2024-04-17 AU AU2024202528A patent/AU2024202528A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021277731B2 (en) | 2024-04-11 |
| CA2989145A1 (fr) | 2016-12-22 |
| AU2016280280A1 (en) | 2018-01-04 |
| US20170296514A1 (en) | 2017-10-19 |
| IL256322A (en) | 2018-02-28 |
| JP2018517734A (ja) | 2018-07-05 |
| AU2024202528A1 (en) | 2024-05-09 |
| US20240091201A1 (en) | 2024-03-21 |
| EP3310354A4 (fr) | 2018-12-12 |
| AU2021277731A1 (en) | 2021-12-23 |
| IL256322B (en) | 2022-03-01 |
| US10265301B2 (en) | 2019-04-23 |
| CN107847490A (zh) | 2018-03-27 |
| AU2016280280B2 (en) | 2021-09-02 |
| US20170027911A1 (en) | 2017-02-02 |
| US11878005B2 (en) | 2024-01-23 |
| US10258608B2 (en) | 2019-04-16 |
| WO2016205658A1 (fr) | 2016-12-22 |
| EP3310354A1 (fr) | 2018-04-25 |
| HK1254608A1 (zh) | 2019-07-26 |
| US20190167643A1 (en) | 2019-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43271A (fr) | Formulations améliorées de déférasirox et leurs procédés de fabrication | |
| MA44869A (fr) | Cellules génétiquement modifiées et leurs procédés de fabrication | |
| DE102016200026B8 (de) | Wafer-Herstellungsverfahren | |
| MA48475A (fr) | Procédés de fabrication de niraparib | |
| ES2969970T3 (es) | Formas sólidas novedosas | |
| MA46474A (fr) | Formulations nanoparticulaires et leurs procédés de production et d'utilisation | |
| KR20180084991A (ko) | 성형체 및 그 제조 방법 | |
| MA53939A (fr) | Compositions hémostatiques et leurs procédés de fabrication | |
| FR3034145B1 (fr) | Etage de compresseur | |
| DK3352950T3 (da) | Industrirobot | |
| MA51879A (fr) | Plaques de plâtre et leurs méthodes de fabrication | |
| DK3304934T3 (da) | Høreapparat | |
| DK3121318T3 (da) | Beklædningsgenstand og fremgangsmåde til fremstilling | |
| DK3307216T3 (da) | Termoformbare halvstive ortoser | |
| DK3257345T3 (da) | Rullende landbrugselement | |
| FR3031743B1 (fr) | Composites polymeriques metalliques souples | |
| DK3374468T3 (da) | Flamme- eller brandhæmmende midler og fremstilling og anvendelse deraf | |
| KR20180084800A (ko) | 마이크로 기계식 요 레이트 센서 및 그 제조 방법 | |
| CL2016001249S1 (es) | Conjunto soplador | |
| DK3664473T3 (da) | Høreapparat | |
| MA46711A (fr) | Polysaccharide et procédés | |
| DK3423594T3 (da) | Oligonukleotider og fremstillingsfremgangsmåder | |
| DK3377781T3 (da) | Selvcentrerende rulleføring | |
| ITUB20152386A1 (it) | Materiale sagomato e procedimento di fabbricazione | |
| ITUA20162131A1 (it) | Fibbia migliorata |